From our preliminary experience, PSMA-PET/MRI altered intended decision-making in 39.3% of patients with suspected PCa, 8.3% of patients with primarily diagnosed PCa, and 63.6% patients with BRPCa respectively. Here, FOLH1 is linked to posterior cortical atrophy.